Ted Torphy, chief scientific officer at Johnson & Johnson, was the moderator at the MassBio Investors Forum at the Sheraton Boston.
(Pat Greenhouse/ Globe Staff)
Mass. biotech firms urged to remain independent
Ted Torphy, chief scientific officer at Johnson & Johnson, was the moderator at the MassBio Investors Forum at the Sheraton Boston.
(Pat Greenhouse/ Globe Staff)
It’s time for pulling up the bootstraps. That was the message delivered to biotechnology start-ups at the 11th annual MassBio Investors Forum yesterday. At a time when major drug makers are consolidating and may be less willing to buy fledgling companies, biotechs have to make it on their own and bring drugs to market themselves. (Full article: 617 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
